Nanofilm Technologies (MZH) H2 2021 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2021 earnings summary
21 Oct, 2026Executive summary
FY2021 revenue rose 13% to S$247m and PAT increased 8% to S$63m, setting record highs despite macro and supply-chain challenges.
2H2021 revenue grew 55% and PAT 145% vs 1H2021; PAT rose 12% YoY to S$44m.
Financial highlights
FY2021 revenue was S$246.7m vs S$218.3m in FY2020; PAT was S$62.5m vs S$58.1m.
PAT attributable to equity holders rose 8.0% to S$62.2m from S$57.6m.
PBT was S$70m; adjusted for S$3m of non-recurring expenses, PBT would have been S$73m.
Outlook and guidance
FY2022 outlook is positive, with confidence in sustainable growth through commercialisation and wider adoption across existing and new industries.
Shanghai Plant 2 and new equipment expanded capacity; the additions are expected to support growth across multiple industries.
Sydrogen is on track for initial revenue from an automotive project in 2H2022.
R&D is advancing greener composites, engineered optics for VR/AR, and hydrogen fuel-cell technologies and components.
Latest events from Nanofilm Technologies
- Capacity investments and segment momentum underpin growth plans amid supply-chain disruption.MZH
Q4 2021 TU - Revenue grew 24.2%, while startup and NPI costs pressured profit and margins.MZH
H1 2021 - 2H recovery lifted earnings and margins, underpinning conditional FY2024 growth expectations.MZH
H2 2023 - Headwinds cut FY2022 results, while expansion and the 2025 targets remained on track.MZH
H2 2022 - Revenue fell 34.4% as consumer weakness drove a H1 loss; 2H revenue is expected higher.MZH
H1 2023 - FY2025 revenue rose 20% and PAT 58%, led by AMBU growth and an IEBU recovery.MZH
H2 2025 - Revenue rose 29.6% as PATMI returned to profit and adjusted EBITDA grew 46.1%.MZH
H1 2025 - Revenue grew 13%, adjusted EBITDA rose 61.4%, and FY2024 growth is expected.MZH
H1 2024 - Revenue rose 15% and adjusted EBITDA 31%, supported by growth and global expansion.MZH
H2 2024